Stroke, Acute Clinical Trial
— SECRETOfficial title:
Stroke in Egyptian Clinical REgisTry
NCT number | NCT03723382 |
Other study ID # | ESS015000 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | May 20, 2018 |
Est. completion date | July 30, 2020 |
This is a multi-institutional registry database for the patients with stroke and
cerebrovascular diseases. Stroke is the second leading cause of death in the Egypt. Despite
extensive research, most of the patients die or suffer from varying degree of post-stroke
disabilities due to neurologic deficits.
This registry aims to understand the disease and examine the disease dynamics at the National
Level. additionally it aim to introduce an objective method for classifying the registered
hospital on a spectrum of 6 level coded with colors (from Black to Green ) according the
availability of the predetermined 5 bundles of services presented for patient
Status | Recruiting |
Enrollment | 50000 |
Est. completion date | July 30, 2020 |
Est. primary completion date | May 19, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - All patients with a diagnosis of Acute Brain injury, Transient Ischemic Attack, Acute and Chronic Ischemic and Hemorrhagic Stroke, Subarachnoid hemorrhage, and cerebral venous thrombosis seen in the registered Centers. - Age > 1 years of age. Exclusion Criteria: - Patients who don't have the diagnosis of Acute Brain injury, Transient Ischemic Attack, Acute and Chronic Ischemic and Hemorrhagic Stroke, Subarachnoid hemorrhage, and cerebral venous thrombosis. - Patients who have Epidural Hematoma, Subdural hematoma. |
Country | Name | City | State |
---|---|---|---|
Egypt | Alexandria University , School of medicine , Neurology Department, Neurovascular Unit | Alexandria |
Lead Sponsor | Collaborator |
---|---|
Society of Minimally Invasive Neurological Therapeutic Procedures | Egyptian Radiology Society, Egyptian Society of Neurological Surgeons, Egyptian Stroke society, Middle East North Africa Stroke and Interventional Neurotherapies Organization |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The National Institutes of Health Stroke Scale (NIHSS) reported | Severity of ischemic stroke and stroke not otherwise specified patients will be weighted with a score reported for NIH Stroke Scale will be grouped into Mild stroke (>0-6 on NIHSS) moderate (>6 - 10 on NIHSS) severe (>10 - 20 on NIHSS) and Grave (>20 on NIHSS) | 30 days post discharge from hospital | |
Primary | Modified Rankin Scale at Discharge | Patients grouped by Modified Rankin Scale at discharge | 90 days post discharge from hospital | |
Primary | Risk-Adjusted Mortality Ratio for Ischemic-Only and Ischemic and Hemorrhagic models | A ratio comparing the actual in-hospital mortality rate to the risk-adjusted expected mortality rate. | 30 days post discharge from hospital | |
Secondary | Disease burden | Quality-Adjusted Life-Years (QALY) : measure of the life expectancy corrected for loss of quality of that life caused by diseases and disabilities. | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05378035 -
DOAC in Chinese Patients With Atrial Fibrillation
|
||
Completed |
NCT03574038 -
Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke
|
N/A | |
Completed |
NCT03679637 -
Tablet-based Aphasia Therapy in the Acute Phase After Stroke
|
N/A | |
Completed |
NCT03633422 -
Evaluation of Stroke Patient Screening
|
||
Completed |
NCT04088578 -
VNS-supplemented Motor Retraining After Stroke
|
N/A | |
Not yet recruiting |
NCT05534360 -
Tenecteplase Treatment in Ischemic Stroke Registry
|
||
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Not yet recruiting |
NCT04105322 -
Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients
|
N/A | |
Withdrawn |
NCT05786170 -
ERILs Und SNILs Unter SOC
|
N/A | |
Recruiting |
NCT03132558 -
Contrast Induced Acute Kidney in Patients With Acute Stroke
|
N/A | |
Completed |
NCT02893631 -
Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
|
||
Active, not recruiting |
NCT02274727 -
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
|
||
Completed |
NCT02225730 -
Imaging Collaterals in Acute Stroke (iCAS)
|
||
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Active, not recruiting |
NCT01581502 -
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
|
N/A | |
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT00761982 -
Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.
|
Phase 1/Phase 2 | |
Completed |
NCT00535197 -
Autologous Bone Marrow Stem Cells in Ischemic Stroke.
|
Phase 1/Phase 2 | |
Terminated |
NCT00132509 -
FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke
|
Phase 2 | |
Recruiting |
NCT05760326 -
Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients
|